An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone wrote in worried that after four weeks on a very low weekly dose of semaglutide they’ve only dropped from 165 to 157.5 pounds, and they aren’t feeling much less hungry. They’re asking if something is wrong because their appetite hasn’t changed, even on the day they inject. This is a report from one person’s experience, not a formal study. Semaglutide is the active drug in prescription medicines like Ozempic and Wegovy. In plain terms, it’s a man-made version of a hormone your gut releases after you eat. That hormone talks to your brain to make you feel fuller and slows how fast your stomach empties. Doctors use semaglutide for type 2 diabetes and, at higher doses, for weight management. People usually start at a low dose and increase slowly to reduce side effects. What this single-person report actually shows is an early, real-world experience on a very small dose over four weeks. It’s common that the weight change in the first month is modest, especially at the lowest starting dose. Appetite effects also vary. Clinical trials that led to approved dosing typically used longer timeframes and stepped-up doses; noticeable appetite suppression and larger weight loss often appear after dose escalation and several months. So this person’s experience is neither unexpected nor proof the drug “doesn’t work” — it’s just an early snapshot at a small dose. Why this matters is practical: people starting semaglutide often expect quick, dramatic appetite loss and fast weight drops because of media stories. Real-world results can be slower. If you or someone you know is on semaglutide, it’s useful to know that starting doses are conservative on purpose, and that behavior changes (like what and how much you eat) still matter. It also means patience and communication with your prescriber are important — they’ll monitor progress and side effects and decide whether to raise the dose. Caveats and risks: this is anecdotal, not a controlled trial, so it can’t tell you how the drug will work for anyone else. Side effects can include nausea, diarrhea, constipation, and sometimes low blood sugar if taken with other diabetes drugs. Semaglutide can take weeks to titrate to an effective dose; staying at the very lowest dose may produce only small effects. People with certain medical histories (like some pancreatitis, certain thyroid cancers, or pregnancy) shouldn’t use it, and it should be prescribed and monitored by a clinician. If appetite or weight changes are concerning, check with your prescriber before changing dose or stopping. Bottom line: At a very low starting dose and after only four weeks, modest weight loss and little appetite change are common; talk with your doctor about dose plans and expectations rather than assuming something is wrong.
Source: r/Semaglutide